advanced search

INJECTION

PREFILLED SAFETY SYRINGE MARKET THRIVES AMID SELF-ADMINISTRATION TREND
EXPERT VIEW
George I’ons
PREFILLED SAFETY SYRINGE MARKET THRIVES AMID SELF-ADMINISTRATION TREND
George I’ons looks at how the growing trend of patient self-administration is driving demand for prefilled safety syringes.
LARGE-VOLUME INJECTORS: RISE IN BIOLOGICS BRINGS CHALLENGES
EXPERT VIEW
Dr Paolo Fiorini
LARGE-VOLUME INJECTORS: RISE IN BIOLOGICS BRINGS CHALLENGES
Developing devices capable of delivering highly viscous biologic drug formulations at high volumes does not come without its challenges. Paolo Fiorini, Gerard Linnane, Michael Kiely, Maciej Grygorczuk and Joshua Coyne discuss these challenges and the merits of various drive solutions.
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
INJECTION
Séverine Duband
Nemera
LEVERAGING THE PATIENT JOURNEY TO OPTIMISE DEVICE USE AT HOME
Séverine Duband and Mark Tunkel discuss the importance of device optimisation to increase patient safety during self-administration of medication.
ADDRESSING THE EVOLVING NEEDS OF VARIABLE DRUG DELIVERY REGIMENS
WEARABLES
Dr Temitope Sodunke
BD (Becton Dickinson & Company)
ADDRESSING THE EVOLVING NEEDS OF VARIABLE DRUG DELIVERY REGIMENS
Temitope Sodunke introduces the BD Evolve™ On-body Injector and describes how the device is designed specifically to address the rapidly evolving needs of the pharma industry and meet patient requirements.
HOW TO DESIGN A BODY-WORN INJECTOR
EXPERT VIEW
Steve Augustyn
HOW TO DESIGN A BODY-WORN INJECTOR
Body-worn injectors require you to understand your user, your drug and your technology – and there are numerous pitfalls for the unwary. Stephen Augustyn shares some insights.
THE NEED FOR CSTDS IN BOTH MANUAL AND AUTOMATED COMPOUNDING
INJECTION
Marino Kriheli
Equashield
THE NEED FOR CSTDS IN BOTH MANUAL AND AUTOMATED COMPOUNDING
Marino Kriheli discusses the benefits of using closed system transfer devices (CSTDs) in both manual and automated hazardous drugs compounding.
FINDING THE RIGHT PACKAGING FOR BIOLOGIC DRUGS
PREFILLED SYRINGES
Christian Helbig
SCHOTT Pharma
FINDING THE RIGHT PACKAGING FOR BIOLOGIC DRUGS
Christian Helbig introduces a new 2.25 mL version of SCHOTT’s syriQ BioPure® prefillable syringes designed specifically for the biologics market and, developed in partnership with WL Gore, the world’s first silicone-free glass syringe system.
THE CHALLENGES OF A CHANGING MARKET & THE BENEFITS OF DEVELOPMENT FLEXIBILITY
INJECTION
David Fink
THE CHALLENGES OF A CHANGING MARKET & THE BENEFITS OF DEVELOPMENT FLEXIBILITY
David Fink and Sheila Trgovac describe how adopting a flexible development model in mid-to-late development brings benefits through to commercialisation, especially in the context of a changing market.
VIDEO: Credence Connect from Credence MedSystems
VIDEO
John Merhige
Credence MedSystems
VIDEO: Credence Connect from Credence MedSystems
Credence MedSystems takes us through the use steps of its new Credence Connect™ autosensing injection system, and smartphone app.
HOW TO DEVELOP A CUSTOMISED IOT PLATFORM WITH A RUNNING START
CONNECTIVITY
Rachel An
HOW TO DEVELOP A CUSTOMISED IOT PLATFORM WITH A RUNNING START
Do you need a drug delivery Internet of Things (IoT) platform across your entire portfolio of drugs that is agnostic to the type of source container, drug viscosity and the volume to be dispensed? Rachel An and Gillian Harding-Moore discuss how to develop such a platform with a running start.
NEXT-GENERATION CONNECTED DRUG DELIVERY SUPPORTS DATA LIQUIDITY & COST SAVINGS
CONNECTIVITY
Neil Williams
Phillips Medisize
NEXT-GENERATION CONNECTED DRUG DELIVERY SUPPORTS DATA LIQUIDITY & COST SAVINGS
Neil Williams discusses medication non-adherence, the toll it takes on the healthcare system and how integration, analytics and more affordable connectivity in drug delivery devices as part of a connected health ecosystem improves patient care and lowers costs.
AN INJECTION OF CONNECTED NEEDLE-FREE INNOVATION
CONNECTIVITY
Barbara Taylor
Portal Instruments
AN INJECTION OF CONNECTED NEEDLE-FREE INNOVATION
Barb Taylor discusses the next generation of needle-free injection devices, which incorporate connectivity.
CHOOSING THE RIGHT CONNECTIVITY FOR DRUG DELIVERY AND MEDICAL PRODUCTS
EXPERT VIEW
Dr Juan Nogueira
CHOOSING THE RIGHT CONNECTIVITY FOR DRUG DELIVERY AND MEDICAL PRODUCTS
Juan Nogueira; Tommaso Borghi and Marco Vergani discuss the factors that need to be taken into account in the selection of connectivity technology for a drug delivery device or other medical product.
PRODUCT SHOWCASE: Injay – Connected Prefilled Syringe
CONNECTIVITY
Biocorp
PRODUCT SHOWCASE: Injay – Connected Prefilled Syringe
Biocorp presents Injay, the first prefilled syringe with built-in connectivity, providing a cost-effective and easy-to-implement solution that improves treatment adherence, upholds quality of reporting, and provides a secure treatment protocol and traceability.
SUCCESS FACTORS FOR THE YPSOMATE FAMILY OF AUTOINJECTORS
INJECTION
Orfeo Niedermann
Ypsomed
SUCCESS FACTORS FOR THE YPSOMATE FAMILY OF AUTOINJECTORS
Orfeo Niedermann looks at the key factors behind the growth and continued success of the YpsoMate family of two-step autoinjectors. He also introduces YpsoMate Design, which enables freeform outer shell design around the proven YpsoMate mechanism and manufacturing lines.
THE INTERFACE BETWEEN PREFILLED SYRINGE AND AUTOINJECTOR – A DEVELOPMENT FRAMEWORK
EXPERT VIEW
Dr Jeffrey Philippson
THE INTERFACE BETWEEN PREFILLED SYRINGE AND AUTOINJECTOR – A DEVELOPMENT FRAMEWORK
Jeffrey Philippson and Tom Kemp outline the challenges for autoinjector developers at the interface between the device and the prefilled syringe – and describe a framework to formalise analysis of the interface.
SIMPLIFYING THE PROCESS OF DEVELOPING PREFILLED SYRINGES
INJECTION
Tibor Hlobik
West Pharmaceutical Services
SIMPLIFYING THE PROCESS OF DEVELOPING PREFILLED SYRINGES
Tibor Hlobik describes how the use of cyclic olefin polymer delivery systems is gaining in popularity because of the benefits they have over glass systems for complex drug applications, and explains what this advance in technology can offer drug manufacturers.
30 YEARS IN THE MAKING – AN INSIDE PERSPECTIVE ON THE EMERGENCE OF AUTOINJECTORS
INJECTION
Michael McGowan
SHL Medical
30 YEARS IN THE MAKING – AN INSIDE PERSPECTIVE ON THE EMERGENCE OF AUTOINJECTORS
Michael McGowan, Director of Market Intelligence at SHL Group, gives a perspective on the emergence of the autoinjector as a key component of the drug delivery industry, in the context of SHL celebrating its 30th anniversary this year – a journey of rapid development that reflects the growing demand for advanced drug delivery systems in the healthcare market. 
DEVELOPMENTS IN SELF-INJECTION DEVICES FOR COMBINATION PRODUCTS
INJECTION
Dr Fred Metzmann
Haselmeier
DEVELOPMENTS IN SELF-INJECTION DEVICES FOR COMBINATION PRODUCTS
Fred Metzmann reports on the latest state-of-the-art developments in innovative injection devices for combination products in subcutaneous self-application. He outlines Haselmeier's product platform strategy for single-use (D-Flex) and re-usable (i-pen²) injection-pen systems, and related services and looks at the company’s connected digital solutions.
LED-GENERATED UV FOR ADHESIVE CURING IN MEDICAL DEVICES
PREFILLED SYRINGES
Roland Lindner
sortimat
LED-GENERATED UV FOR ADHESIVE CURING IN MEDICAL DEVICES
Roland Lindner, Matthias Schulze and Bill Jaworski discuss how the needs around adhesive use in the manufacture of medical devices such as glass syringes have evolved and how ATS sortimat has developed a new process to meet industry demands.
F2V: A STERILE, CUSTOMISABLE LIQUID FILL-FINISH PLATFORM FOR THE TOTAL LIFECYCLE
INDUSTRIALISATION
Simon Strothers
3P Innovation
F2V: A STERILE, CUSTOMISABLE LIQUID FILL-FINISH PLATFORM FOR THE TOTAL LIFECYCLE
Simon Strothers presents an integrated fill-finish platform, F2V, designed to represent a commercial filling system as a bench-top solution. The article also includes a recent case study where the F2V was used by Consort Medical to help develop and industrialise a flagship delivery device. 
PATIENTS, MANUFACTURERS & PRACTITIONERS CAN LEAD ADOPTION OF CONNECTED COMBINATION PRODUCTS
EXPERT VIEW
Napoleon Monroe
PATIENTS, MANUFACTURERS & PRACTITIONERS CAN LEAD ADOPTION OF CONNECTED COMBINATION PRODUCTS
Napoleon Monroe asks why connectivity has failed to advance rapidly, and argues that many stakeholders can benefit if the adoption of connectivity for drug delivery can be accelerated. While this article will centre on pharmaceutical combination products, the essential points also relate more broadly to pharmaceuticals and medical devices.
ASSESSING USABILITY EARLY FOR OPTIMAL INJECTION PEN DESIGN
INJECTION
David Fink
ASSESSING USABILITY EARLY FOR OPTIMAL INJECTION PEN DESIGN
David Fink and Stefan Gaul use the example of Haselmeier’s D-Flex system to explain why it is important to undertake a full use-related risk analysis for injection pen products to assess their usability and identify any risks, highlighting the importance of considering usability right from the start.
LATEST UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
PREFILLED SYRINGES
Tomohiro Suzuki
Mitsubishi Gas Chemical
LATEST UPDATE ON OXYCAPT™ MULTILAYER PLASTIC VIAL AND SYRINGE
Tomohiro Suzuki gives an update on the development of the OXYCAPT™ multilayer plastic vial and syringe – highlighting the results of recent tests comparing it with existing glass syringes.
Top